Cytokines and the malnutrition of chronic renal failure

Mineral and Electrolyte Metabolism

Volumn 23, Issue 3-6, 1997, Pages 237-242

  Abdullah, M S ^a   Wild, G ^a   Jacob, V ^a   Milford Ward, A ^a   Ryad, R ^b   Zanaty, M ^b   Ali, M H ^b   El Nahas, A M ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Chronic renal failure; Insulin like growth factor I; Interleukin 1 ; Interleukin 6; Malnutrition; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANTHROPOMETRIC PARAMETERS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DIETARY INTAKE; FEMALE; HUMAN; MALE; MALNUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SKINFOLD THICKNESS;

ADULT; AGED; ANTHROPOMETRY; CASE-CONTROL STUDIES; CYTOKINES; DIET, PROTEIN-RESTRICTED; ENERGY INTAKE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; PROTEIN-ENERGY MALNUTRITION; REGRESSION ANALYSIS;

EID: 0030686487     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Lowrie EG, Lew NL: Death risks in hemodialysis patients: The predictive value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482
2. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P: Markers for survival in dialysis: A seven-year prospective study. Am J Kidney Dis 1995;26:209-219.
3. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 1991;17:462-471.
4. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 1996;50:343-357.
5. Zumkeller W, Schofield PN: The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch B Cell Pathol 1992;62:207-220.
6. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uraemia and hemodialysis on circulating interleukin-1 and tumour necrosis factor-α. Kidney Int 1990;37:116-125.
7. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA: Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD, and haemodialysis patients. Kidney Int 1994;45:890-896.
8. Jacob V, Le Carpentier JE, Salazano S, Naylor V, Wild G, Brown CB, El Nahas AM: IGF-I, a marker of undernutrition in haemodialysis patients. Am J Clin Nutr 1990;52:39-44.
9. Jacob V, Marchant PR, Wild G, Brown CB, Moorhead PJ, El Nahas AM: Nutritional profile of continuous ambulatory peritoneal dialysis patients. Nephron 1995;71:16-22.
10. McMurray J, Abdullah I, Dargie H, Shapiro D: Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 1991;66:356-358.
11. Mooradian AD, Reed RL, Meredith KE, Scuderi P: Serum levels of tumour necrosis factor-α and IL-1β in diabetic patients. Diabetes Care 1991;14:63-65.
12. Mooradian A, Reed R, Osterweel D, Scuderi P: Detectable serum levels of tumour necrosis factor-α may predict early mortality in elderly institutionalized patients. J Am Geriatr Soc 1991;39:891-894.
13. Detsky AS, Mc Laughlin JR, Baker JP, Johston N, Jeejeebhoy KN: What is Subjective Global Assessment of nutritional status? J Parent Enter Nutr 1987;11:8-13.
14. Metropolitan Height and Weight Table. Stat Bull 1983;64:Jan-Jun.
15. Heymsfield SB, Mc Manus CB, Seitz SB, Nixon DW, Andrews JS: Anthropometric assessment of adult protein-energy malnutrition; in Wright RA, Heymsfield SB (eds): Nutritional Assessment. Cambridge, Blackwell, 1984, pp 27-77.
16. Campher C: Nutrition assessment in chronic renal failure. Nutr Support Serv 1985;7:18-21.
17. Ikizler TA, Greene J, Wingard RL, Parker RA, hakim RM: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995;6:1386-1391.
18. El Nahas AM, Coles GA: Dietary treatment of chronic renal failure: Ten unanswered questions. Lancet 1986,i:597-600.
19. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877-884.
20. Underwood LE, Clemmons DR, Maes M, D'Ercole AJ, Ketelsegers E: Regulation of somatomedin-C/insulin-like growth factor-I by nutrients. N Engl J Med 1991;325:695.
21. El Nahas AM, Sayed-Ahmed N: IGF-1 and the kidney: Friend or foe? Exp Nephrol 1993;1:205-217.
22. Ikizler TA, Wingard RL, Hakim RM: Interventions to treat malnutrition in dialysis patients: The role of the dose of dialysis, intradialytic parenteral nutrition and growth hormone. Am J Kidney Dis 1995;26:256-265.
23. Isley WL, Underwood LE, Clemmons DR: Dietary components that regulate serum somatomedin C concentration in humans. J Clin Invest 1983;71:175-182.
24. Peng S, Fouque D, Kopple J: Insulin-like growth factor-I causes anabolism in malnourished CAPD patients. J Am Soc Nephrol 1993;4:414.
25. Wilmore DW: Catabolic illness: Strategies for enhancing recovery. N Engl J Med 1991;325:695.
26. Mille SB, Moulton M, O'Shea M, Hammermann MR: Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 1994;46:201-207.
27. McNamara MJ, Alexander HR, Norton JA: Cytokines and their role in the pathophysiology of cancer cachexia. J Parent Enter Nutr 1990;16(suppl):S50-S55.
28. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW: Infusion of tumour necrosis factor/cachectin promotes muscle catabolism in the rat: A synergistic effect with interleukin-1. J Clin Invest 1989;83:1614-1622.
29. Nawabi MD, Block KP, Chakrabarti MC: Administration of endotoxin, tumour necrosis factor or interleukin-1 to rats activates skeletal muscle branched alpha-ketoacid dehydrogenase. J Clin Invest 1990;85:256-263.
30. Mealy K, Lonschot JB van, Robinson BG, Rounds J, Wilmore DW: Are the catabolic effects of tumour necrosis factor-α mediated by glucocorticoids? Arch Surg 1990;125:42-48.
31. Plata-Salaman CR, O'omura Y, Kai Y: Tumour necrosis factor-α and interleukin-1β: Suppression of food intake by direct action in the central nervous system. Brain Res 1988;448:106-114.
32. Robert A, Olafsson AS, Lancaster C, Zhang W: IL-1 is cytoprotective, antisecretory, stimulates prostaglandin E2 synthesis by stomach, and retards gastric emptying. Life Sci 1991;48:123-134.
33. Otterness IG, Golden HW, Seymour PA, Eskra JD, Daumy GO: Role of prostaglandins in the behavioral changes induced by murine IL-1 in the rat. Cytokine 1991;3:333-338.
34. Daun JM, Mc Carthy DO: The role of cholecystokinin in IL-1-induced anorexia. Physiol Behav 1993;54:237-241.